Результаты поиска - Alan L. Ho

Отмена результатов
  1. 1
    The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent

    The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent по Jayasree S. Nair, Alan L. Ho, Gary K. Schwartz

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Regulation of Late G<sub>1</sub>/S Phase Transition and APC<sup>Cdh1</sup>by Reactive Oxygen Species

    Regulation of Late G<sub>1</sub>/S Phase Transition and APC<sup>Cdh1</sup>by Reactive Oxygen Species по Courtney G. Havens, Alan L. Ho, Naohisa Yoshioka, Steven F. Dowdy

    Опубликовано 2006
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy

    Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy по Robert M. Samstein, Alan L. Ho, Nancy Y. Lee, Christopher A. Barker

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Androgen Receptor Signaling in Salivary Gland Cancer

    Androgen Receptor Signaling in Salivary Gland Cancer по Martin G. Dalin, Philip A. Watson, Alan L. Ho, Luc G.T. Morris

    Опубликовано 2017
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  5. 5
    Correlation of <i>BRAF</i><sup><i>V600E</i></sup> Mutation and Glucose Metabolism in Thyroid Cancer Patients: An <sup>18</sup>F-FDG PET Study

    Correlation of <i>BRAF</i><sup><i>V600E</i></sup> Mutation and Glucose Metabolism in Thyroid Cancer Patients: An <sup>18</sup>F-FDG PET Study по James Nagarajah, Alan L. Ho, R. Michael Tuttle, Wolfgang Weber, Ravinder K. Grewal

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death

    Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death по Grazia Ambrosini, Elgilda Musi, Alan L. Ho, Elisa de Stanchina, Gary K. Schwartz

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G<sub>1</sub> Cyclin-Dependent Kinase Complexes In Vivo

    Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G<sub>1</sub> Cyclin-Dependent Kinase Complexes In Vivo по Sergei A. Ezhevsky, Alan L. Ho, Michelle Becker‐Hapak, Penny K. Davis, Steven F. Dowdy

    Опубликовано 2001
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts

    Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts по Nora Katabi, Ronald Ghossein, Alan L. Ho, Snjezana Doğan, Lei Zhang, Yun‐Shao Sung, Cristina R. Antonescu

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype

    Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype по Alan L. Ho, Elgilda Musi, Grazia Ambrosini, Jayasree S. Nair, Shyamprasad Deraje Vasudeva, Elisa de Stanchina, Gary K. Schwartz

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780

    Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780 по Jayasree S. Nair, Alan L. Ho, Archie Tse, Jesse Coward, Haider Cheema, Grazia Ambrosini, Nicholas Keen, Gary K. Schwartz

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    PDGF Receptor Alpha Is an Alternative Mediator of Rapamycin-Induced Akt Activation: Implications for Combination Targeted Therapy of Synovial Sarcoma

    PDGF Receptor Alpha Is an Alternative Mediator of Rapamycin-Induced Akt Activation: Implications for Combination Targeted Therapy of Synovial Sarcoma по Alan L. Ho, Shyamprasad Deraje Vasudeva, Marick Laé, Tsuyoshi Saito, Violetta Barbashina, Cristina R. Antonescu, Marc Ladanyi, Gary K. Schwartz

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    The evolving landscape of salivary gland tumors

    The evolving landscape of salivary gland tumors по Conor Steuer, Glenn J. Hanna, Kartik Viswanathan, James E. Bates, Azeem Kaka, Nicole C. Schmitt, Alan L. Ho, Nabil F. Saba

    Опубликовано 2023
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  13. 13
    Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands

    Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands по Bin Xu, Esther Drill, Allen S. Ho, Alan L. Ho, Lara Dunn, Carlos Nicolas Prieto-Granada, Timothy A. Chan, Ian Ganly, Ronald Ghossein, Nora Katabi

    Опубликовано 2017
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    The immune microenvironment and expression of PD‐L1, PD‐1, PRAME and MHC I in salivary duct carcinoma

    The immune microenvironment and expression of PD‐L1, PD‐1, PRAME and MHC I in salivary duct carcinoma по Bin Xu, Achim A. Jungbluth, Denise Frosina, Bayan Alzumaili, Nathaniel Aleynick, Elzbieta Slodkowska, Kevin Higgins, Alan L. Ho, Luc G.T. Morris, Ronald Ghossein, Nora Katabi

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

    Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma по Vatche Tchekmedyian, Eric J. Sherman, Lara Dunn, Crystal Tran, Shrujal S. Baxi, Nora Katabi, Cristina R. Antonescu, Irina Ostrovnaya, Sofia Haque, David G. Pfister, Alan L. Ho

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

    A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSC... по Lara Dunn, Matthew G. Fury, Han Xiao, Shrujal S. Baxi, Eric J. Sherman, Susan Korte, Christian Pfister, Sofia Haque, Nora Katabi, Alan L. Ho, David G. Pfister

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer

    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer по Eric J. Sherman, Lara Dunn, Alan L. Ho, Shrujal S. Baxi, Ronald Ghossein, Matthew G. Fury, Sofia Haque, Cami S. Sima, Grace Cullen, James A. Fagin, David G. Pfister

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Distant metastasis of salivary gland cancer: Incidence, management, and outcomes

    Distant metastasis of salivary gland cancer: Incidence, management, and outcomes по Ximena Mimica, Marlena McGill, Ashley Hay, Daniella K. Zanoni, Jatin P. Shah, Richard J. Wong, Alan L. Ho, Marc A. Cohen, Snehal G. Patel, Ian Ganly

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma

    Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma по Johanna C. Bendell, Valérie André, Alan L. Ho, Ragini R. Kudchadkar, Michael R. Migden, Jeffrey R. Infante, Ramón V. Tiu, Celine Pitou, Trevor Tucker, Les Brail, Daniel D. Von Hoff

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers

    Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers по Brian R. Untch, Vanessa Dos Anjos, María E.R. García-Rendueles, Jeffrey A. Knauf, Gnana P. Krishnamoorthy, Mahesh Saqcena, Umesh Bhanot, Nicholas D. Socci, Alan L. Ho, Ronald Ghossein, James A. Fagin

    Опубликовано 2018
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: